The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 57.00
Bid: 56.00
Ask: 58.00
Change: 0.00 (0.00%)
Spread: 2.00 (3.571%)
Open: 57.00
High: 57.00
Low: 57.00
Prev. Close: 57.00
MAV4 Live PriceLast checked at -
Maven Income and Growth VCT 4 is an Investment Trust

To achieve long term capital appreciation and generate income by investing the majority of its funds in a diversified portfolio of shares and securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Supplementary Prospectus

29 Mar 2023 14:19

RNS Number : 6537U
Maven Income and Growth VCT 3 PLC
29 March 2023
 

Joint Announcement

Maven Income and Growth VCT PLC, Maven Income and Growth VCT 3 PLC, Maven Income and Growth VCT 4 PLC, and Maven Income and Growth VCT 5 PLC (the "Companies")

Issue of Supplementary Prospectus

The Boards of the Companies today announce that they have published a supplementary prospectus (the "Supplementary Prospectus") relating to the offers for subscription issued by the Companies, details of which were set out in their prospectus (comprising a securities note, registration document and summary) issued on 7 October 2022.

The publication of the Supplementary Prospectus is a regulatory requirement under the Prospectus Regulation Rules and Section 87G of The Financial Services and Market Act 2000 following the publication by each of Maven Income and Growth VCT 3 PLC (on 14 March 2023) and Maven Income and Growth VCT 5 PLC (on 23 March 2023) of their respective Annual Report and Financial Statements for the year ended 30 November 2022.

 

The Supplementary Prospectus has been approved by the Financial Conduct Authority, and a copy will shortly be available for inspection at the National Storage Mechanism, which is located at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism. Copies of the Supplementary Prospectus are available free of charge from the office of the investment manager of the Companies, Maven Capital Partners UK LLP, at Kintyre House, 205 West George Street, Glasgow G2 2LW and from the website of Maven Capital Partners UK LLP at: www.mavencp.com/vctoffer.

Enquiries

For further information, please contact:

Maven Capital Partners UK LLP

Tel: 0141 306 7400

E-mail: enquiries@mavencp.com

Maven Capital Partners UK LLP

Secretary

29 March 2023

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDISEFFDUEDSEFD
Date   Source Headline
14th Nov 200811:37 amRNSResult of EGM
14th Nov 200811:14 amRNSInterim Management Statement
29th Aug 200812:19 pmRNSCircular re GM, and issue of
14th Aug 200811:31 amRNSInterim Results
7th Aug 200812:49 pmRNSDirectorate Change
19th May 20083:30 pmRNSInterim Management Statement
15th May 20083:50 pmRNSAGM Statement
7th May 20089:30 amRNSAnnual Information Update
6th May 200811:36 amRNSAnnual Report and Accounts
12th Mar 200811:00 amRNSDividend Declaration
28th Feb 20084:36 pmRNSFinal Results
12th Sep 20072:56 pmRNSInterim Results
1st Aug 20071:19 pmRNSTotal Voting Rights
1st Aug 20071:15 pmRNSIssue of Equity
13th Jul 20073:06 pmRNSIssue of Equity
28th Jun 20074:20 pmRNSExtension of Offer period
12th Jun 20074:40 pmRNSAnnual Information Update
11th Jun 20074:47 pmRNSResult of AGM
10th Apr 20074:32 pmRNSIssue of Equity
2nd Apr 20074:19 pmRNSIssue of Equity
1st Mar 20074:38 pmRNSIssue of Equity
23rd Feb 20073:04 pmRNSFinal Results
20th Dec 20064:54 pmRNSTotal Voting Rights
5th Dec 200611:14 amRNSDividend Declaration
8th Nov 20062:20 pmRNSNet Asset Value(s)
6th Oct 20063:52 pmRNSPublication of Prospectus
5th Oct 20064:25 pmRNSEGM Statement
5th Oct 20062:54 pmRNSDividend Declaration
5th Oct 200612:54 pmRNSDividend Declaration
6th Sep 20064:23 pmRNSNotice of EGM
23rd Aug 20064:28 pmRNSInterim Results
22nd Jun 20069:36 amRNSAnnual Information Update
21st Jun 20069:13 amRNSResult of AGM
8th Feb 20064:46 pmRNSFinal Results
1st Dec 20054:30 pmRNSInvestment Activity
1st Nov 20053:59 pmRNSDirectorate Change
15th Sep 200511:52 amRNSFurther re Issue of Equity
12th Sep 20058:41 amRNSIssue of Equity
31st Aug 20054:25 pmRNSInterim Results
2nd Jun 20051:14 pmRNSIssue of Equity
6th Apr 200510:14 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.